ResearchMoz presents this most up-to-date research on “United States Bacterial Conjunctivitis Drugs Market – Pipeline Assessment, Size, Share, Growth, Trends and Forecast 2017 – 2024”.
Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity. This study provides market analysis for various antibacterial drug classes used for the treatment of bacterial conjunctivitis. The stakeholders of this study comprise established pharmaceutical companies involved in the commercialization of antibacterial drugs as well as new participants who wish to enter the U.S. market.
- Vancomycin Ophthalmic Ointment
- Early Stage (Phase I and Phase II trials) – Tabular Representation